Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy.
Recent reports indicate that orbital irradiation for Graves' ophthalmopathy is sometimes beneficial, particularly for dysthyroid optic neuropathy, and is not associated with serious complications. We are aware, however, of four patients who were found to have radiation retinopathy after orbital irradiation for Grave's ophthalmopathy. All four patients have decreased central acuity, and three of the four are legally blind in one or both eyes. Computer reconstruction of the dosimetry, based on computed tomography and beam profiles, shows that errors in dosage calculations and radiotherapy technique probably account for the radiation retinopathy in three of the four patients. Radiotherapy for Graves' ophthalmopathy should be administered only by competent radiotherapists who are experienced in the treatment of this disease. Similar errors in dosage calculations and treatment techniques may account for other reports of radiation retinopathy after reportedly safe dosages.
D000328:Adult; D000368:Aged; D001766:Blindness / Q000209:etiology / Q000473:pathology; D003037:Cobalt Radioisotopes / Q000009:adverse effects; D005260:Female; D006111:Graves Disease / Q000150:complications* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009915:Orbit; D011832:Radiation Injuries / Q000209:etiology* / Q000473:pathology; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012164:Retinal Diseases / Q000209:etiology* / Q000473:pathology; D014792:Visual Acuity / Q000528:radiation effects
D003037:Cobalt Radioisotopes; D007457:Iodine Radioisotopes